Skin Tissue Engineering Part II — The In Vitro Evaluation of Natural and Synthetic 3-D Matrices as Dermal Substrates

Biodegradable Systems in Tissue Engineering and Regenerative Medicine

Volumn , Issue , 2004, Pages 529-548

  Ng, K W ^a   Khor, H L ^a   Hutmacher, Dietmar W ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78449303139     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203491232-37     Document Type: Chapter

References (30)

1. Teumer, J., Hardin-Young, J., and Parenteau, N.L., Tissue engineered skin, in Frontiers in Tissue Engineering, Patrick, C.W., Jr., Mikos, A.G., and Mcintire, L.V., Eds., Elsevier Science Ltd., Oxford, 1998, pp. 664–677.
2. Hutmacher, D.W. and Vanscheidt, W., Matrices for tissue-engineered skin, Drugs Today, 38, 113, 2002.
3. Andreassi, L. et al., Human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid suitable for grafting, Wounds, 3, 116, 1991.
4. Naughton, G., Mansbridge, J., and Gentzkow, G., A metabolically active human dermal replacement for the treatment of diabetic foot ulcers, Artif. Org., 21, 1203, 1997.
5. Hardin-Young, J. and Parenteau, N.L., Bilayered skin constructs, in Methods of Tissue Engineering, Atala, A. and Lanza, R.P., Eds., Academic Press, San Diego, 2002, p. 1177.
6. Retrieved from http://www.ortecinternational.com
7. Gentzkow, G.D. et al., Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers, Diab. Care, 4, 350, 1996.
8. Eaglstein, W.H. and Falanga, V., Tissue engineering and the development of apligraf, a human skin equivalent, Adv. Wound Care, 11 (Suppl. 1), 8, 1998.
9. Bilbo, P.R., Nolte, C.J.M., and Oleson, M.A., Skin in complex culture: The transition from "culture" phenotype to organotypic phenotype, J. Toxicol. Cutaneous Ocul. Toxicol., 12, 183, 1993.
10. Pham, H.T. et al., Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective randomized, clinical trial, Wounds, 11, 79, 1999.
11. Ng, C.S. et al., Simultaneous biaxial drawing of poly(ɛ-caprolactone) films, Polymer, 41, 5855, 2000.
12. Ng, K.W. et al., The evaluation of ultra-thin poly(e-caprolactone) films for tissue engineering skin, Tissue Eng., 7, 441, 2001.
13. Khor, H.L. et al., Poly(ɛ-caprolactone) films as a potential substrate for tissue engineering an epidermal equivalent, Mater. Sci. Eng. C: Biomim. Supramol. Sys., 20, 71, 2002.
14. Ouyang, H.W. et al., The efficacy of bone marrow stromal cell-seeded knitted PLGA fiber scaffold for achilles tendon repair, Ann. N.Y. Acad. Sci., 961, 126, 2002.
15. Ang, T.H., Burdet, E., and Teoh, S.H., Fabrication of 3D chitosan-hydroxyapatite scaffolds using a robotic dispensing system, Sci. Eng. C, 20, 35, 2002.
16. Lamme, E.N. et al., Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation, J. Pathol., 190, 595, 2000.
17. Clark, R.A.F., Overview and general considerations of wound repair, in The Molecular and Cell Biology of Wound Repair, Clark, R.A.F. and Henson, P.M., Eds., New York, Plenum Press, 1998, pp. 3–23.
18. Spector, M., Novel cell-scaffold interactions encountered in tissue engineering: contractile behaviour of musculoskeletal connective tissue cells, Tissue Eng., 8, 351, 2002.
19. Majno, G. et al., Contraction of granulation tissue in vitro: similarity to smooth muscle, Science, 173, 548, 1971.
20. Imaizumi, T. et al., Effect of human basic fibroblast growth factor on fibroblast proliferation, cell volume, collagen lattice contraction: in comparison with acidic type, J. Dermatol. Sci., 11, 134, 1996.
21. Wainwright, D.J., Use of an acellular allograft dermal matrix (alloderm) in the management of fullthickness burns, Burns, 21, 243, 1995.
22. Ojeh, N.O., Frame, J.D., and Navsaria, H.A., In vitro characterization of an artificial scaffold, Tissue Eng., 7, 457, 2001.
23. Mattioli-Belmonte, M., Muzzarelli, B., and Muzzarelli, R.A.A., Chitin and chitosan in wound healing and other biomedical applications, Carbohydr. Eur., 19, 30, 1997.
24. Howling, G.I. et al., The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro, Biomaterials, 22, 2959, 2001.
25. Chung, L.Y. et al., Biocompatibility of potential wound management products: fungal mycelia as a source of chitin/chitosan and their effects on the proliferation of human F1000 fibroblasts in culture, J. Biomed. Mater. Res., 28, 463, 1994.
26. Mori, T. et al., Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro, Biomaterials, 18, 947, 1997.
27. Prohaska, H.J. and Santamaria, A.B., Quinone reductase from cells cultured in microliter wells: a screening assay for anti-carcinogenic enzyme inducers, Anal. Biochem., 169, 328, 1988.
28. Zolnai, A. et al., Comparison of 3H-thymidine incorporation and CellTiter 96 aqueous colorimetric assays in cell proliferation of bovine mononuclear cells, Acta Vet. Hung., 46, 191, 1998.
29. Berger, P., Tryptase and agonists of par-2 induce the proliferation of human airway smooth muscle cells, J. Appl. Physiol., 91, 1372, 2001.
30. Yan, M., The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes, FASEB J., 15, 1132, 2001.